SE410312B - Forfarande for framstellning av vissa angivna oximetrar - Google Patents

Forfarande for framstellning av vissa angivna oximetrar

Info

Publication number
SE410312B
SE410312B SE7603341A SE7603341A SE410312B SE 410312 B SE410312 B SE 410312B SE 7603341 A SE7603341 A SE 7603341A SE 7603341 A SE7603341 A SE 7603341A SE 410312 B SE410312 B SE 410312B
Authority
SE
Sweden
Prior art keywords
oximeters
procedure
manufacture
certain stated
stated
Prior art date
Application number
SE7603341A
Other languages
English (en)
Swedish (sv)
Other versions
SE7603341L (sv
Inventor
H B A Welle
V Claassen
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of SE7603341L publication Critical patent/SE7603341L/xx
Publication of SE410312B publication Critical patent/SE410312B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7603341A 1975-03-20 1976-03-17 Forfarande for framstellning av vissa angivna oximetrar SE410312B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (2)

Publication Number Publication Date
SE7603341L SE7603341L (sv) 1976-09-21
SE410312B true SE410312B (sv) 1979-10-08

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603341A SE410312B (sv) 1975-03-20 1976-03-17 Forfarande for framstellning av vissa angivna oximetrar

Country Status (27)

Country Link
US (1) US4085225A (pl)
JP (1) JPS6026776B2 (pl)
AR (2) AR211011A1 (pl)
AT (1) AT340895B (pl)
AU (1) AU505358B2 (pl)
BE (1) BE839744A (pl)
CA (1) CA1076142A (pl)
CH (4) CH626057A5 (pl)
DD (1) DD128332A5 (pl)
DE (1) DE2610886A1 (pl)
DK (1) DK144942C (pl)
ES (1) ES446192A1 (pl)
FI (1) FI61875C (pl)
FR (1) FR2304336A1 (pl)
GB (1) GB1535226A (pl)
GR (1) GR60052B (pl)
HU (1) HU171030B (pl)
IE (1) IE43768B1 (pl)
IL (1) IL49238A (pl)
IT (1) IT1063064B (pl)
MX (1) MX9203723A (pl)
NL (1) NL7503310A (pl)
PL (3) PL101951B1 (pl)
SE (1) SE410312B (pl)
SU (3) SU635867A3 (pl)
YU (1) YU39345B (pl)
ZA (1) ZA761434B (pl)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
WO1997006792A1 (en) * 1995-08-16 1997-02-27 Eli Lilly And Company Potentiation of serotonin response
IN182588B (pl) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (pl) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
EP1276478A2 (en) 2000-04-24 2003-01-22 ARYx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
NZ532033A (en) * 2001-10-12 2006-11-30 Azevan Pharmaceuticals Inc 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives as vasopressin V1a receptor antagonists
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
CA2532207A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
DE602004024317D1 (de) 2003-09-12 2010-01-07 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
US7671072B2 (en) * 2003-11-26 2010-03-02 Pfizer Inc. Aminopyrazole derivatives as GSK-3 inhibitors
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
MXPA06012165A (es) * 2004-04-29 2007-01-17 Keystone Retaining Wall System Chapas para muros, muros de contencion y similares.
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
EP1868434A4 (en) 2005-03-22 2011-10-26 Azevan Pharmaceuticals Inc BETA-LACTAMYL ALKANIC ACIDS FOR THE TREATMENT OF PREMIERSTRUELLEN FAULTS
AU2006239942A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
AU2006239897A1 (en) * 2005-04-22 2006-11-02 Wyeth Crystal forms of {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
AU2006239920A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
JP2008538573A (ja) * 2005-04-22 2008-10-30 ワイス ベンゾフラニルアルカナミン誘導体およびその５−ｈｔ２ｃアゴニストとしての使用
US20070015138A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
TR201907381T4 (tr) 2005-07-19 2019-06-21 Azevan Pharmaceuticals Inc Beta-laktamil fenilalanin, sistein ve serin vazopressin antagonisti.
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CN101410112A (zh) * 2006-03-24 2009-04-15 惠氏公司 治疗抑郁症的新治疗组合
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
ES2585806T3 (es) 2009-10-23 2016-10-10 Janssen Pharmaceutica N.V. Octahidropirrolo [3,4-c] pirroles disustituidos como moduladores de receptores de orexina
EP2509596B1 (en) 2009-12-08 2019-08-28 Case Western Reserve University Gamma aminoacids for treating ocular disorders
ES2662350T3 (es) 2010-07-01 2018-04-06 Azevan Pharmaceuticals, Inc. Procedimientos para el tratamiento del trastorno por estrés postraumático
US20140010883A1 (en) 2011-03-17 2014-01-09 Lupin Limited Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
US9783492B2 (en) 2013-04-03 2017-10-10 Zcl Chemicals Limited Process for the preparation of fluvoxamine maleate
US10124006B2 (en) 2014-02-07 2018-11-13 MTA Tämogatott Kutatócsoportok Irodája Use of Sigma-1 receptor agonist compounds
AU2015237253B2 (en) 2014-03-28 2019-11-14 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
HRP20220642T1 (hr) 2016-03-10 2022-06-24 Janssen Pharmaceutica Nv Postupci za liječenje depresije uporabom antagonista receptora oreksina 2
MA46898A (fr) 2016-11-24 2019-10-02 Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag Compositions pour la conservation d'organes
MY208313A (en) 2017-09-15 2025-04-30 Azevan Pharmaceuticals Inc Compositions and methods for treating brain injury
US20240024288A1 (en) 2019-07-19 2024-01-25 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
YU71476A (en) 1982-10-31
DK144942B (da) 1982-07-12
FR2304336A1 (fr) 1976-10-15
DK144942C (da) 1982-12-06
DE2610886A1 (de) 1976-10-07
SU620206A3 (ru) 1978-08-15
SE7603341L (sv) 1976-09-21
YU39345B (en) 1984-10-31
PL100614B1 (pl) 1978-10-31
CH629761A5 (de) 1982-05-14
CH629184A5 (de) 1982-04-15
AU505358B2 (en) 1979-11-15
AT340895B (de) 1978-01-10
FI61875C (fi) 1982-10-11
US4085225A (en) 1978-04-18
DD128332A5 (de) 1977-11-09
JPS6026776B2 (ja) 1985-06-25
FR2304336B1 (pl) 1979-09-28
IL49238A0 (en) 1976-05-31
ZA761434B (en) 1977-10-26
JPS51125345A (en) 1976-11-01
GR60052B (en) 1978-04-04
DE2610886C2 (pl) 1987-09-24
IL49238A (en) 1978-08-31
CH626057A5 (pl) 1981-10-30
AU1214776A (en) 1977-09-22
FI760699A7 (pl) 1976-09-21
DK115976A (da) 1976-09-21
ATA195476A (de) 1977-05-15
BE839744A (fr) 1976-09-20
GB1535226A (en) 1978-12-13
AR211011A1 (es) 1977-10-14
SU635867A3 (ru) 1978-11-30
SU645559A3 (ru) 1979-01-30
IE43768B1 (en) 1981-05-20
AR211153A1 (es) 1977-10-31
PL100052B1 (pl) 1978-08-31
MX9203723A (es) 1992-07-01
IT1063064B (it) 1985-02-11
FI61875B (fi) 1982-06-30
NL7503310A (nl) 1976-09-22
IE43768L (en) 1976-09-20
CH629477A5 (de) 1982-04-30
ES446192A1 (es) 1977-10-01
HU171030B (hu) 1977-10-28
CA1076142A (en) 1980-04-22
PL101951B1 (pl) 1979-02-28

Similar Documents

Publication Publication Date Title
SE7603341L (sv) Sett att framstella nya oximeterforeningar
NL7607338A (nl) Werkwijze voor de bereiding van 1,4-dihydro- pyrinederivaten met vaatverwijdende en bloed- drukverlagende activiteit.
AU510466B2 (en) Blood substitute based on haemoglobin
AU503525B2 (en) Guanidines, thioureas and 2, 2-diamino-1-nitroethylene derivatives
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
NL191332C (nl) Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.
IT7921692A0 (it) Prodotto dotato di attivita&#39; sul cervello.
USD243517S (en) Snowmobile track
TR20394A (tr) 2,4-cift ikameli-5-tiazolkarboksilik asitler ve tuerevler
SE7410757L (pl)
SE7905922L (sv) N-(diaminofosfinyl)-arylkarboxamider
FR2358160A1 (fr) Produit destine a declencher la parturition, a faciliter la fecondation et a augmenter la lactation chez la femme et chez les mammiferes, notamment le betail
BE842927A (fr) Procede cyvlique d&#39;oxychlorhydratation d&#39;ethylene avec emissions d&#39;hydrpcarbures reduutes et dichlorure d&#39;ethylenene ainsi obtenu
AU570552B2 (en) 1,4-dihydropyridine-3-carboxylates and salts thereof
SE8301997L (sv) Framstellning av 6,11-dihydro-11-oxodibens(b,e)-oxepin-2-ettiksyra
NL7902153A (nl) Meta-fenoxybenzylesters van fenylalkaanzuren, alsmede insecticiden en acariciden op basis daarvan.
BG34607A3 (bg) Фунгицидно средство
USD243123S (en) Tibial template for knee joint reconstruction
AT348505B (de) Verfahren zur herstellung von 2,6-di- tert.butylphenol
USD245208S (en) Shoe
USD245207S (en) Shoe
USD245210S (en) Shoe
ES8306467A1 (es) Procedimiento para la preparacion de alfa-hidroxiacidos.
SU523652A1 (ru) Культиватор дл ухода за лесными культурами
IT7927782A0 (it) Procedimento per la fabbricazione di pantofole specialmente pianelle ed articoli da calzare cosi&#39;ottenuti.

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7603341

SPCG Supplementary protection certificate granted

Free format text: 7603341, EXPIRES: 20010317

NAL Patent in force

Ref document number: 7603341-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7603341-4

Format of ref document f/p: F